Format

Send to

Choose Destination
Expert Opin Ther Targets. 2003 Jun;7(3):411-25.

TNF-receptor-associated factors as targets for drug development.

Author information

1
The Burnham Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA. jzapata@burnham.org

Abstract

TNF-receptor-associated factors (TRAFs) are the bottleneck of the TNF-receptor (TNF-R) family signal transduction. They integrate the signalling from many members of the TNF-R family and initiate intracellular signalling cascades aimed at the activation of NF-kappaB and c-jun, the reprogramming of gene expression and the control of cell death. Deregulation of these pathways is the cause of several autoimmune and inflammatory diseases. The specificity and interaction of the members of the TRAF family with the TNF-R entails the recognition of just a 4 - 6 amino acid motif in the cytosolic region of the receptor, suitable as an attractive target for drug discovery. This review summarises the current knowledge on TRAFs and discusses the pros and cons of their application as targets for drug discovery.

PMID:
12783577
DOI:
10.1517/14728222.7.3.411
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center